Dietary Interventions for Inflammatory Bowel Disease

(AID-IBD Trial)

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: McMaster University

No Placebo Group

Trial Summary

What is the purpose of this trial?

In this study, we are trying to learn how certain diets affect people with inflammatory bowel disease (IBD). We want to understand what makes it hard or easy for them to stick to different eating plans, like intermittent fasting, the Mediterranean diet, and the Low FODMAP diet. By finding out how these diets help with symptoms and which ones are easier to follow, we hope to improve the quality of life for people with IBD.

Research Team

Eligibility Criteria

This trial is for individuals with IBD, including Ulcerative Colitis and Crohn's Disease. Participants should be interested in testing how different diets may impact their condition.

Inclusion Criteria

I am willing to use my smartphone for the trial app.

I am over 18 and have been diagnosed with ulcerative colitis or Crohn's disease.

Able to understand the indication by the registered dietitian

Exclusion Criteria

I have diabetes.

I have advanced chronic kidney disease.

I have short bowel syndrome.

Treatment Details

Interventions

• Intermittent Fasting Intervention (Behavioural Intervention)
• Low FODMAP Diet Intervention (Behavioural Intervention)
• Mediterranean Diet Intervention (Behavioural Intervention)

Trial Overview The study examines the effects of three diet interventions on IBD symptoms: intermittent fasting, Mediterranean diet, and Low FODMAP diet. It also assesses participants' adherence to these eating plans.

Participant Groups

Group I: Mediterranean Diet Experimental Treatment 1 Intervention

Participants will be assigned to follow a Mediterranean diet.

Group II: Low FODMAP Diet Experimental Treatment 1 Intervention

Participants will be assigned to follow a Low FODMAP Diet.

Group III: Intermittent Fasting Experimental Treatment 1 Intervention

Participants will be assigned to follow an intermittent fasting protocol.

Who Is Running the Clinical Trial?

McMaster University

Lead Sponsor

Trials

936

Recruited

2,630,000+

Evan Stein

McMaster University

Chief Medical Officer since 2015

MD, PhD

Sam

McMaster University

Chief Executive Officer since 2023

MBA from McMaster University